Novavax, Inc. Aktie News
7,27 $
0,95 %
vorgestern
Nasdaq,
9. Januar, 22:14 Uhr
tracken
Novavax, Inc. Aktie News
Neutral
PRNewsWire
●
4 Tage alt
GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P.
Negativ
The Motley Fool
●
etwa ein Monat alt
Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look that exciting either.
Neutral
Investopedia
●
etwa ein Monat alt
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
Negativ
Market Watch
●
etwa ein Monat alt
Memo also reportedly mentions vaccines for flu and pneumonia.
Negativ
Barrons
●
etwa ein Monat alt
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Neutral
Seeking Alpha
●
etwa 2 Monate alt
Novavax, Inc. ( NVAX ) Jefferies London Healthcare Conference 2025 November 19, 2025 11:30 AM EST Company Participants Ruxandra Draghia-Akli - Executive VP and Head of Research & Development James Kelly - Executive VP, CFO & Treasurer Conference Call Participants Jiale Song - Jefferies LLC, Research Division Presentation Jiale Song Jefferies LLC, Research Division Welcome to Jefferies London He...
Negativ
Reuters
●
etwa 2 Monate alt
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no progress is made in the next four months.
Neutral
PRNewsWire
●
2 Monate alt
GAITHERSBURG, Md. , Nov. 12, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Jefferies London Healthcare Conference: Fireside Chat Date: Wednesday, November 19, 2025 Time: 4:30 p.m.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
